ReviewOncoTargets and therapy2018

Brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma: an evidence-based review.

Eva M Donato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.